DarioHealth (DRIO) Earnings Analysis

DarioHealth (DRIO) next reports earnings on 2026-08-11, consensus EPS -0.74 USD. Last quarter (2026-03-19) it beat with EPS -0.8 USD vs -2.44 USD est (+67.2%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 2.37.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DRIO next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.74 USD
Revenue estimate0.01B

DRIO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-19-0.8 USD-2.44 USD+67.2%Beat
2025-11-13-1.85 USD-2.63 USD+29.7%Beat
2025-05-14-1.2 USD-1.4 USD+14.3%Beat
2025-03-100.2 USD-3.2 USD+106.3%Beat
2024-11-07-2.6 USD-3.6 USD+27.8%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

DRIO valuation and analyst view

Trailing P/E2.37
Trailing EPS1.264 USD
Price / book6.29
Dividend yield0.00%
Market cap0.05B
Analyst consensusBuy (8 buy / 1 hold / 0 sell)
Avg price target16 USD

Related research pages

Frequently asked questions

When is DarioHealth (DRIO)'s next earnings date?

DarioHealth is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.74 USD and revenue estimate of 0.01B.

Did DRIO beat earnings last quarter?

In its 2026-03-19 report, DRIO posted EPS of -0.8 USD versus a -2.44 USD estimate — a beat of 67.2%.

What is DRIO's earnings track record?

Over the last 5 reported quarters with consensus data, DRIO beat estimates 5 times (100%).

What is DRIO's current P/E ratio and EPS?

DRIO trades at a trailing P/E of 2.37 on trailing EPS of 1.2635865576537737 USD.

What do analysts rate DRIO?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 16 USD.